DNA oligos were synthesized by Integrated DNA Technologies (IDT). Ampicillin and chloramphenicol, heparin sodium salt from porcine intestinal mucosa, nickel (II) chloride hexahydrate and Benzonase were obtained from Sigma-Aldrich. Isopropyl β-D-1-thiogalactopyranoside (IPTG) was purchased from UBPBio. Ni-NTA agarose beads were obtained from Qiagen. DTSSP (3,3´dithiobis[sulfosuccinimidylpropionate]), yeast tRNA, RNase A were purchased from ThermoFisher Scientific. Luciferase GL3 Duplex was purchased from Dharmacon. Quant-iT™ RiboGreen™ RNA Reagent was obtained from Invitrogen. The Luciferase assay system was obtained from Promega.
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Experimental section
Cloning of CCMV variants
The pET-15b-G-H 6 -CCMV(ΔN26) as well as pET-15b-G-H 6 -ELP-CCMV(ΔN26) vectors encoding for the hexahistidine-tagged-CCMV proteins (V1 and V2) were previously constructed. 1, 2 For the construction of variant 3 and 4 a set of DNA oligos, encoding for the entire ELP insert were designed and ordered (Table S2 ). These oligos were annealed at 95 °C and slowly cooled to room temperature. The resulting inserts encoded for a hexahistidine tag and 9 ELP repeats with sticky ends compatible with 5'
NcoI and 3' XhoI annealing. The pET-15b vector was digested with NcoI and XhoI and the product was purified by agarose gel electrophoresis. Subsequently, the inserts were ligated into the digested vector.
These plasmids were transformed into E. coli XL1-BLUE cells, the DNA was extracted and the sequences were confirmed by DNA sequencing (Table S2 ). For expression, the plasmids were transformed into E.
coli BLR(DE3)pLysS cells (Novagen, MERCK). Table S3 . Amino acid sequences and Q-TOF results of all proteins.
Name Sequence
V3-1 5'CATGGGCCATCATCATCATCATCACGTTCCGGGCGTCGGTGTTCCTGGACGTGGTGTTCCAGGTGTAG GTGTTCCAGGACTCGGTGTTCCTGGTGTAGGTGTTCCTGGTTTAGGTGTTCCAGGTGGCGGTGTTCCTGG TGTGGGAGTTCCTGGTTTAGGTC3' V3-2 5'TCGAGACCTAAACCAGGAACTCCCACACCAGGAACACCGCCACCTGGAACACCTAAACCAGGAACAC CTACACCAGGAACACCGAGTCCTGGAACACCTACACCTGGAACACCACGTCCAGGAACACCGACGCCC GGAACGTGATGATGATGATGATGGCC3' V4-1 5'CATGGGCACTCGTGCACAACGAAGGCATCATCATCATCATCACGTTCCGGGCGTCGGTGTTCCTGGAT TAGGTGTTCCAGGTGTAGGTGTTCCAGGACTCGGTGTTCCTGGTGTAGGTGTTCCTGGTTTAGGTGTTCC AGGTGGCGGTGTTCCTGGTGTGGGAGTTCCTGGTTTAGGTC3' V4-2 5'TCGAGACCTAAACCAGGAACTCCCACACCAGGAACACCGCCACCTGGAACACCTAAACCAGGAACAC CTACACCAGGAACACCGAGTCCTGGAACACCTACACCTGGAACACCTAATCCAGGAACACCGACGCCC GGAACGTGATGATGATGATGATGCCTTCGTTGTGCACGAGTGCC3'
General protocol for the expression of His6-ELP-CCMV variants
CCMV variants were expressed according to a standard expression procedure. 2,3 E. coli BLR(DE3)pLysS cells containing pET-15b-CCMV vectors were inoculated overnight at 37 °C in LB medium (50 mL) containing Ampicillin (100 mg L -1 ) and Chloramphenicol (50 mg L -1 ). Subsequently, LB cultures were inoculated in 2YT medium (1 L) containing Ampicillin (100 mg L -1 ). Cultures were grown at 37 °C till an OD 600 of 0.5 was reached. IPTG (1 mM) was added and bacteria were grown at 30 °C for 6 hours.
Cells were harvested by centrifugation at 2700 g for 15 minutes at 4 °C. Finally the cell pellet was stored overnight at -20°C. The cell pellet was resuspended in Lysis buffer (25 mL). Subsequently, cell lysate was obtained by ultrasonic disruption (3 times 30 seconds, 70 % amplitude, Branson Sonifier 150) and centrifuged at 16400 g for 15 minutes at 4 °C in order to remove cellular debris. The supernatant was incubated for one hour with Ni-NTA agarose beads (3 mL) at 4 °C. Finally, protein solutions were loaded onto a column. The flow-through was collected followed by two washing steps with Wash buffer. Proteins were eluted using the Elution buffer (1 time 0.5 mL, 7 times 1.5 mL). All fractions containing the CCMV protein were combined and dialyzed (12-14 kDa tubing) against dimer buffer pH 7.5 for 1.5 hours (buffer changed 3 times) and against capsid buffer overnight at 4 °C. Proteins were characterized by SDS-PAGE, SEC, Q-TOF, TEM and DLS.
Crosslinking of CCMV Nanoparticles.
For a typical crosslinking procedure, ELP-CCMV capsids (V2) were first dialyzed in pH 5 buffer without EDTA (12-14 kDa MWCO, 3x 30 minutes at 4 °C). Protein samples (100 μM) were incubated with Ni 2+ for 30 minutes at 4 °C according to a 10:1 molar excess of Ni 2+ to capsid proteins. Protein solutions were dialyzed against PBS₁ (12-14 kDa MWCO, 3 times 30 minutes at 4°C) and incubated with DTSSP for one hour at room temperature to a final protein concentration of 50 μM. Finally, samples were dialyzed in PBS pH 7.2 (12-14 kDa MWCO, 3 times 30 minutes at 4 °C) and analyzed by DLS, SEC or TEM. siRNA or tRNA loaded CCMV nanoparticles (V1) were crosslinked according to the same procedure described above without the intermediate step involving Ni 2+ stabilization.
Cargo-Induced Assembly and Loading Efficiency
Protein solutions were dialyzed in dimer buffer pH 7.2 (12-14 kDa MWCO, 3x 30 minutes at 4 °C) and
analyzed by DLS to assess particle disassembly. Capsid proteins were subsequently incubated with siRNA/tRNA (together with 10 eq of Ni 2+ for the ELP-CCMV variants V2, V3 and V4) for 30 minutes at 4 °C according to a 6:1 mass ratio of CP to oligonucleotides. The resulting virus-like particles were analyzed with DLS or TEM. For a standard evaluation of cargo loading agarose gel electrophoresis (running conditions: 1% agarose gel in 50 mM Tris buffer pH 7.2, 50V 40 minutes) together with UV-vis spectroscopy and Ribo green assay (according to manufacturer's instructions) were performed. Samples were analyzed immediately after siRNA/tRNA encapsulation as well as after dialysis in PBS and at the end of the crosslinking reaction.
Determination of the Efficacy of siRNA Encapsulation in Crosslinked Particles
Prior to transfection, HeLa-Luc cells were grown on 96-well plates at 37 °C in a CO₂ incubator till 70% confluency. DMEM supplied with 10% (v/v) FBS and Penicillin-Streptomycin were used as culture medium. siRNA loaded crosslinked V1 nanoparticles (20 μM CP) as well as siRNA alone (0.068 g L −1 )
were incubated for 2 h at room temperature with Benzonase or PBS. Samples were diluted in Opti-MEM five times and incubated at room temperature for 5 minutes. A Lipofectamine solution (2 % v/v) was prepared in the same medium and incubated at room temperature for 5 minutes. Sample solutions and Lipofectamine solutions were mixed (1:1 v/v)| and incubated at room temperature for 10 minutes. HeLa-Luc cells were washed twice with PBS and 100 μL of Optimem were added per well. Finally, 50 μL of the final solutions were used for the inoculation and cells were incubated at 37 °C. After 12 hours, solutions were replaced with fresh complete medium and cells were incubated at 37 °C for two days.
Transfection efficacy was finally analyzed exploiting the Luciferase assay kit (Promega). Briefly, cells were washed twice with PBS before incubation with Lysis buffer (20 L per well). After 20 minutes the Luciferase assay reagent was added (100 L per well) and luminescence determined with a plate-reading Luminometer. 
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